Happy New Year folks! 
First of all, I’d like to share the news – Stem Cell Assays was recognized and awarded as “Stem cell blog of the year 2012” by fellow blogger Paul Knoepfler. We are feeling proud about this achievement!
Every year we share some site statistics with you. It was very productive year for us. We were trying to post 3-4 times per week and were experimenting with different series and topics. Unfortunately, it was lack of feedback about site content. We hope that in new year we can engage community in dialogue more than before. We’re also hoping to attract new advertisers and supporters.
2012 site metrics:
number of visits: ~58 000 (including ~24 000 unique visitors);
number of pageviews; ~106 000
number of regular subscribers (RSS + email): ~350 (including 285 email subscribers)
Dynamics of visits and pageviews monthly:
2010-2012 trends:
Stem Cell Assays is more than 3 years old. So, we can analyze and share some trends now.
Visits and pageviews:
regular subscribers:
Site readership:
As results of our poll:
Site traffic sources:
Major sources of referral traffic:
- LinkedIn: 30%
- twitter (t.co): 22%
- CellTranpl.ru: 7%
Search traffic top 5 keywords:
- “lineage negative”
- “stem cell assays”
- “sphere formation assay”
- “hemocytometer calculator”
- “pluritest”
The most popular posts in 2012:
1. Counting cells with hemocytometer – online protocols (2926 views)
2. What is lineage-negative cells? (2423 views)
3. 10 companies to watch in 2012 (2211 views)
4. Cell therapy industry – market size and more predictions (1954 views)
5. FACS analysis of mouse hematopoietic stem cell subsets – gating strategy (1785 views)
The most popular posts, written in 2012:
1. 10 companies to watch in 2012 (2211 views)
2. Stem cell therapeutic products on the market (1416 views)
3. Trends in regenerative medicine industry – from 2007 to 2011 (888 views)
4. Series of retractions from Amy Wagers’ stem cell lab (822 views)
5. Is human VSEL stem cells a real thing? (698 views)
As you can see, there was no much interest to assays and methods, but it was to industry-related information.
The most popular discussions in 2012:
Posts yielded more than 3 comments:
1. Is human VSEL stem cells a real thing?
2. Stem cell company’s press-release under the microscope
3. Potency assays for mesenchymal stromal cell-based products
4. CD34 expression on human mesenchymal stromal cells
5. Till & McCulloch Meetings 2012 – Reflections on Caplan’s view of mesenchymal stem cells
6. Analysis of the quality of autologous cord blood stored in private banks
Dear readers, we would like to ask you – what do you think about this blog? What posts were the most valuable for you last year? What was a failure? Do you think Cells Weekly is distraction from the main theme or good addition? What are your suggestions for us in new year? Please share your thoughts!
PS: Web tools used for metrics: Google Analytics and FeedBurner.
{ 3 comments… read them below or add one }
Hi Alexey,
This is very interesting data on your blog. I should do a post like this too for mine as I also track my stats.
It’s neat to see your traffic growing so fast and see who is visiting your site and why.
Congratulations!
Paul
Congrats Alexey! It is well-deserved praise. I really get a lot of information from your site. You also forgot to mention at least 1 citation–Advances in Biochemical Engineering/Biotechnology, “Mesenchymal stem cells – origin and characteristics, functions and perspectives for clinical use” M. Dominici ed, 2012, 1-35, DOI: 10.1007/10_2012_141 Springer Publishing Co. Happy New Year! Looking forward to more info. from stemcellassays.com. Cheers, Ali
Thanks a lot for citation Aline!